{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:43:20Z","timestamp":1792701800602,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Major bleeding is associated with poor hospital prognosis in patients with acute coronary syndrome (ACS). Despite its clinical importance, there are limited studies on the incidence and risk factors for major bleeding in ACS patients with dual anti-platelet therapy (DAPT) without access to revascularization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed data from 19,186 patients on DAPT after ACS with no access to revascularization from Clinical Pathway for Acute Coronary Syndrome in China Phase 3 (CPACS-3) cohort, which was conducted from 2011 to 2014. Major bleeding included intracranial hemorrhage, clinically significant bleeding, or bleeding requiring blood transfusion. Factors associated with in-hospital major bleeding were assessed using Poisson regressions with generalized estimating equations to account for the clustering effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 75 (0.39%) patients experienced major bleeding during hospitalization. Among subtypes of ACS, 0.65% of patients with STEMI, 0.33% with NSTEMI, and 0.13% with unstable angina had in-hospital major bleeding (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). The patients who experienced major bleeding had a longer length of stay (median 12 vs. 9 days, <jats:italic>p<\/jats:italic> = 0.011) and a higher all-cause in-hospital death rate (22.7 vs. 3.7%, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). Multivariable analysis showed advancing age (RR = 1.52 for every 10 years increase, 95% CI: 1.13, 2.05), impaired renal function (RR = 1.79, 95% CI: 1.10, 2.92), use of fibrinolytic drugs (RR = 2.93, 95% CI: 1.55, 5.56), and severe diseases other than cardiovascular and renal diseases (RR = 5.56, 95% CI: 1.10, 28.07) were associated with increased risk of major bleeding, whereas using renin\u2013angiotensin system inhibitors (RR = 0.54, 95% CI: 0.36, 0.81) was associated with decreased risk of major bleeding. These independent factors together showed good predictive accuracy with an AUC of 0.788 (95% CI: 0.734, 0.841).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among ACS patients on DAPT, advancing age, impaired renal function, thrombolytic treatment, and severe comorbidities were independently associated with a higher risk of in-hospital major bleeding.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.878270","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T09:26:25Z","timestamp":1667208385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["In-hospital major bleeding in patients with acute coronary syndrome medically treated with dual anti-platelet therapy: Associated factors and impact on mortality"],"prefix":"10.3389","volume":"9","author":[{"given":"Yihong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Weintraub","year":"2001","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jacc.2015.01.047","article-title":"Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention","volume":"65","author":"Kazi","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jcin.2016.04.037","article-title":"The impact of timing of ischemic and hemorrhagic events on mortality after percutaneous coronary intervention: the ADAPT-DES study","volume":"9","author":"Brener","year":"2016","journal-title":"JACC Cardiovasc Interv."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"PRECISE-DAPT Study Investigators","volume":"389","author":"Costa","year":"2017"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.jacc.2016.02.064","article-title":"Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS","volume":"67","author":"Baber","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijcard.2017.10.103","article-title":"Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score","volume":"254","author":"Raposeiras-Roub\u00edn","year":"2018","journal-title":"Int J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.amjcard.2015.12.048","article-title":"Comparison of the global registry of acute coronary events risk score versus the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC\/AHA guidelines risk score to predict in-hospital mortality and major bleeding in acute coronary syndromes","volume":"117","author":"Manzano-Fern\u00e1ndez","year":"2016","journal-title":"Am J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.amjcard.2020.01.010","article-title":"Impact of anemia on the risk of bleeding following percutaneous coronary interventions in patients =75 years of age","volume":"125","author":"Mart\u00ed","year":"2020","journal-title":"Am J Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"ESC Scientific Document Group","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"MASTER DAPT Investigators. Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.jacc.2021.08.074","article-title":"XIENCE 90 and XIENCE 28 Investigators. Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI","volume":"78","author":"Valgimigli","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"TRILOGY ACS Investigators. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4244\/EIJ-D-20-01197","article-title":"Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis","volume":"17","author":"Piccolo","year":"2021","journal-title":"EuroIntervention"},{"key":"B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/CIRCOUTCOMES.115.002084","article-title":"Revascularization trends in patients with diabetes mellitus and multivessel coronary artery disease presenting with non-ST elevation myocardial infarction: insights from the national cardiovascular data registry acute coronary treatment and intervention outcomes network registry-get with the guidelines (NCDR ACTION Registry-GWTG)","volume":"9","author":"Pandey","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/HPC.0b013e3181f01eac","article-title":"CPACS investigators. Clinical pathways for acute coronary syndromes in China: protocol for a hospital quality improvement initiative","volume":"9","author":"Rong","year":"2010","journal-title":"Crit Pathw Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/jamacardio.2019.0897","article-title":"CPACS-3 Investigators. Effect of a quality of care improvement initiative in patients with acute coronary syndrome in resource-constrained hospitals in China: a randomized clinical trial","volume":"4","author":"Wu","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.amjcard.2010.12.009","article-title":"In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry\u00ae-GWTG\u2122","volume":"107","author":"Mathews","year":"2011","journal-title":"Am J Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e012157","DOI":"10.1161\/JAHA.119.012157","article-title":"Development and validation of a novel risk score for in-hospital major bleeding in acute myocardial infarction: the SWEDEHEART score","volume":"8","author":"Simonsson","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/heartjnl-2015-307686","article-title":"ACCOAST Investigators. Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel","volume":"101","author":"Widimsky","year":"2015","journal-title":"Heart."},{"key":"B25","first-page":"542","article-title":"On Behalf of China PEACE Study Group; Transradial Percutaneous Coronary Intervention at Urban Hospitals of China in 2006 and 2011\u2014Results from China PEACE-Retrospective CathPCI Study","volume":"32","author":"Xin","year":"2017","journal-title":"Chin Circ J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.ehj.2004.08.016","article-title":"TIMI Study Group. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials","volume":"25","author":"Gibson","year":"2004","journal-title":"Eur Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","article-title":"Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials","volume":"4","author":"Mehran","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e014611","DOI":"10.1161\/JAHA.119.014611","article-title":"Sex-related differences in patients at high bleeding risk undergoing percutaneous coronary intervention: a patient-level pooled analysis from 4 postapproval studies","volume":"9","author":"Chandiramani","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jacc.2019.01.051","article-title":"Effect of angiotensin II inhibitors on gastrointestinal bleeding in patients with left ventricular assist devices","volume":"73","author":"Converse","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","article-title":"Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding","volume":"134","author":"Tabit","year":"2016","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/heartjnl-2016-310090","article-title":"TRILOGY ACS Investigators. Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes","volume":"103","author":"Alfredsson","year":"2017","journal-title":"Heart."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"DAPT Study Investigators. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/eurheartj\/ehr422","article-title":"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"32","author":"Becker","year":"2011","journal-title":"Eur Heart J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3389\/fphar.2020.571605","article-title":"A New Score for Predicting Acute Gastrointestinal Bleeding in Patients Administered Oral Antiplatelet Drugs","volume":"11","author":"Lv","year":"2021","journal-title":"Front Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","article-title":"Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients","volume":"75","author":"Cao","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e008307","DOI":"10.1161\/CIRCINTERVENTIONS.119.008307","article-title":"Application of the academic research consortium high bleeding risk criteria in an all-comers registry of percutaneous coronary intervention","volume":"12","author":"Natsuaki","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.jacc.2016.09.957","article-title":"Bleeding events before coronary angiography in patients with non-st-segment elevation acute coronary syndrome","volume":"68","author":"Redfors","year":"2016","journal-title":"J Am Coll Cardiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.878270\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T09:26:29Z","timestamp":1667208389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.878270\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":38,"alternative-id":["10.3389\/fcvm.2022.878270"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.878270","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"article-number":"878270"}}